HALO logo
halo search icon
Amneal Pharmaceuticals, Inc. Class A

US$12.23

Price Change Indicator
0.42 (3.56%)
Amneal Pharmaceuticals, Inc. Class A
AMRX · NAS

Amneal Pharmaceuticals, Inc. Class A

Start Trading AMRX for Free

US$12.23

Price Arrow0.42 (3.56%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapEMA 125 BreakdownFakey Shakey - LongFakey Shakey - Long (Realtime)HALO AllHALO Capital Efficiency+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Amneal Pharmaceuticals, Inc. Class A Overview

AMRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About AMRX

icon
icon

Telephone

1.908.947.3120

icon

Address

3rd floor, 400 Crossing Boulevard, Bridgewater, NJ 08807

Description

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

AMRX Price Chart

Key Stats

Market Cap

US$3.77B

PE

56.80

EV/EBITDA

10

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 7.02 - 15.42

Trade Value (12mth)

US$5,427,263.00

1 week

-1.01%

1 month

-9.29%

YTD

-6.71%

1 year

62.45%

All time high

52.10

Key Fundamentals

EPS 3 yr Growth

-126.70%

EBITDA Margin

21.40%

Operating Cashflow

$340m

Free Cash Flow Return

14.30%

ROIC

3.00%

Interest Coverage

2.70

Quick Ratio

1.50

Other Data

Shares Outstanding (Fully Diluted)

329m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AMRX Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

AMRX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.48-0.380.23locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.48-0.380.22locklocklock
Growth
 %locklocklocklock44.620.7160.8locklocklock
PE
 XlocklocklocklockN/AN/A56.8locklocklock
EV/EBITDA
 Xlocklocklocklock7.58.410locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS)?
Halo FAQ
The current share price of Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) is USD$12.23.
What is the 52-week high share price for Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS)?
Halo FAQ
The 52-week high share price for Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) is USD$15.42.
What is the 52-week low share price for Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS)?
Halo FAQ
The 52-week low share price for Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) is USD$7.02.
What is the dividend yield for Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS)?
Halo FAQ
Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) does not pay a dividend.
What was Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) last dividend payment?
Halo FAQ
Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) does not pay a dividend.
What is the franking level for Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS)?
Halo FAQ
Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) has a franking level of 0.00%.
In which sector is Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) classified?
Halo FAQ
Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS)?
Halo FAQ
The current P/E ratio for Amneal Pharmaceuticals, Inc. Class A (AMRX:NAS) is 56.80.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial